150 related articles for article (PubMed ID: 11179764)
1. Determination of loss of heterozygosity in frozen and paraffin embedded tumors by denaturating high-performance liquid chromatography (DHPLC).
Kleymenova E; Walker CL
J Biochem Biophys Methods; 2001 Jan; 47(1-2):83-90. PubMed ID: 11179764
[TBL] [Abstract][Full Text] [Related]
2. Transformation of kidney epithelial cells by a quinol thioether via inactivation of the tuberous sclerosis-2 tumor suppressor gene.
Yoon HS; Monks TJ; Walker CL; Lau SS
Mol Carcinog; 2001 May; 31(1):37-45. PubMed ID: 11398196
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat.
Yeung RS; Xiao GH; Everitt JI; Jin F; Walker CL
Mol Carcinog; 1995 Sep; 14(1):28-36. PubMed ID: 7546222
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
6. Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone.
Lau SS; Monks TJ; Everitt JI; Kleymenova E; Walker CL
Chem Res Toxicol; 2001 Jan; 14(1):25-33. PubMed ID: 11170505
[TBL] [Abstract][Full Text] [Related]
7. The genetic basis of kidney cancer: why is tuberous sclerosis complex often overlooked?
Henske EP
Curr Mol Med; 2004 Dec; 4(8):825-31. PubMed ID: 15579029
[TBL] [Abstract][Full Text] [Related]
8. Interstitial chromosomal deletion of the tuberous sclerosis complex 2 locus is a signature for radiation-associated renal tumors in Eker rats.
Inoue T; Kokubo T; Daino K; Yanagihara H; Watanabe F; Tsuruoka C; Amasaki Y; Morioka T; Homma-Takeda S; Kobayashi T; Hino O; Shimada Y; Kakinuma S
Cancer Sci; 2020 Mar; 111(3):840-848. PubMed ID: 31925975
[TBL] [Abstract][Full Text] [Related]
9. Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat.
Habib SL; Phan MN; Patel SK; Li D; Monks TJ; Lau SS
Carcinogenesis; 2003 Mar; 24(3):573-82. PubMed ID: 12663520
[TBL] [Abstract][Full Text] [Related]
10. [Tests for loss of heterozygosity in tuberous sclerosis].
Jóźwiak S; Dabora S; Kasprzyk-Obara J; Domańska-Pakieła D; Grajkowska W
Przegl Lek; 2001; 58 Suppl 1():12-5. PubMed ID: 11355103
[TBL] [Abstract][Full Text] [Related]
11. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene.
Yeung RS; Xiao GH; Jin F; Lee WC; Testa JR; Knudson AG
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11413-6. PubMed ID: 7972075
[TBL] [Abstract][Full Text] [Related]
12. Tuberin haploinsufficiency is associated with the loss of OGG1 in rat kidney tumors.
Habib SL; Simone S; Barnes JJ; Abboud HE
Mol Cancer; 2008 Jan; 7():10. PubMed ID: 18218111
[TBL] [Abstract][Full Text] [Related]
13. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.
Al-Saleem T; Wessner LL; Scheithauer BW; Patterson K; Roach ES; Dreyer SJ; Fujikawa K; Bjornsson J; Bernstein J; Henske EP
Cancer; 1998 Nov; 83(10):2208-16. PubMed ID: 9827727
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas.
Parry L; Maynard JH; Patel A; Clifford SC; Morrissey C; Maher ER; Cheadle JP; Sampson JR
Br J Cancer; 2001 Oct; 85(8):1226-30. PubMed ID: 11710839
[TBL] [Abstract][Full Text] [Related]
15. Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features.
Bjornsson J; Short MP; Kwiatkowski DJ; Henske EP
Am J Pathol; 1996 Oct; 149(4):1201-8. PubMed ID: 8863669
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Labenski M; Mastrandrea NJ; Canatsey RD; Monks TJ; Lau SS
Mol Carcinog; 2016 Aug; 55(8):1243-50. PubMed ID: 26333016
[TBL] [Abstract][Full Text] [Related]
17. TSC2 gene mutant (Eker) rat model of a Mendelian dominantly inherited cancer.
Hino O; Fukuda T; Satake N; Kobayashi T; Honda S; Orimoto K; Yamashita Y; Kikuchi Y
Prog Exp Tumor Res; 1999; 35():95-108. PubMed ID: 10377754
[No Abstract] [Full Text] [Related]
18. Allelic loss at the predisposing gene locus in spontaneous and chemically induced renal cell carcinomas in the Eker rat.
Kubo Y; Mitani H; Hino O
Cancer Res; 1994 May; 54(10):2633-5. PubMed ID: 8168090
[TBL] [Abstract][Full Text] [Related]
19. Tuberous sclerosis gene products in proliferation control.
Hengstschläger M; Rodman DM; Miloloza A; Hengstschläger-Ottnad E; Rosner M; Kubista M
Mutat Res; 2001 Jul; 488(3):233-9. PubMed ID: 11397651
[TBL] [Abstract][Full Text] [Related]
20. Denaturing high-performance liquid chromatography (DHPLC) is a highly sensitive, semi-automated method for identifying mutations in the TSC1 gene.
Roberts PS; Jozwiak S; Kwiatkowski DJ; Dabora SL
J Biochem Biophys Methods; 2001 Jan; 47(1-2):33-7. PubMed ID: 11179759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
